- Home
- NEO vs RNP Comparison
NEO vs RNP Comparison
Compare NEO & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEO | RNP |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 959.9M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEO | RNP |
|---|---|---|
| Price | $7.90 | $20.72 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.14 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 115.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | N/A |
| Revenue Next Year | $9.73 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $19.00 |
| 52 Week High | $13.74 | $22.99 |
Technical Indicators
Market Signals| Indicator | NEO | RNP |
|---|---|---|
| Relative Strength Index (RSI) | 19.28 | 36.84 |
| Support Level | $7.07 | $19.90 |
| Resistance Level | $8.89 | $20.69 |
| Average True Range (ATR) | 0.47 | 0.28 |
| MACD | -0.11 | -0.16 |
| Stochastic Oscillator | 2.30 | 2.50 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.